In a news release dated March …
Read News ArticleCategory: Latest News
What’s New in MS Research – March 2019
The opening months of 2019 saw significant research advances on many fronts in multiple sclerosis (MS). A sophisticated analysis of data using healthcare claims found that the number of people in the United States living with MS is more than twice as high as previously estimated. Dietary studies sounded a cautionary note for people with MS drinking soda and many other sweetened beverages, and a hopeful note on the potential for flavonoid-rich cocoa to reduce MS-associated fatigue. A promising stem-cell therapy is moving forward in the clinical-trials process, while the FDA is considering whether to approve a new disease-modifying therapy (DMT).
Read News ArticleMultiple Sclerosis Association of America Focuses 2019 MS Awareness Month Campaign on MS and the Family
The Multiple Sclerosis Associa …
Read News ArticleMultiple Sclerosis Association of America Appoints Alexandra von Plato to Board of Directors
The Multiple Sclerosis Associa …
Read News ArticleWhat’s New in MS Research: January 2019
This installment of “What’s New in MS Research” highlights the breadth of that research, as the nine studies reported below examine everything from a possible link between food allergies and MS disease activity, to the promise of stem cell transplantation in people who have not obtained a satisfactory response from multiple disease-modifying therapies (DMTs). Important studies on the potential causes of MS, the role of patient preferences in drug selection and adherence, and other topics also are covered.
Read News ArticleWhat’s New in MS Research: Highlights from the 2018 ECTRIMS Annual Meeting
This year’s gathering was held in Berlin, Germany, October 10-12, where the findings were presented from hundreds of studies on topics ranging from the safety and effectiveness of investigational medications to the role of diet in controlling symptoms of MS.
Read News ArticleWhat’s New in MS Research: September 2018
Research into the causes, diagnosis, impact, and management of multiple sclerosis (MS) continues to move forward on a broad front and at a rapid pace. While many advances are announced at medical meetings, such as the annual gatherings of the American Academy of Neurology (AAN), American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Consortium of Multiple Sclerosis Centers (CMSC), and European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), other findings are reported in medical journals throughout the year.
Read News ArticleEmergency Preparedness Resources
In the event of a disaster in your area, make sure you can access emergency services.
Read News ArticleIn Memory of Robert Rapp
The entire staff at the Multip …
Read News ArticleFDA Accepts Application for Cladribine Tablets
EMD Serono, Inc. announced tod …
Read News Article